Join our pharmaceutical impurities webinars to hear from leaders in the field how you can optimize your impurity analysis workflows to obtain greater productivity, sensitivity, accuracy and reproducibility to meet increasing regulatory requirements and lower limits of detection. Learn how to achieve all of this, while also increasing laboratory efficiency and reducing the cost per sample.
Each webinar will allow time for questions and will be 40-50 minutes in duration. Audio will be available by phone only and not via PC. The dial-in information will be provided with the confirmation email.
Overview of Pharmaceutical Impurities and Reference Standards
Tuesday, 11 December 2018, 11:00 CET | 10:00 GMT
An overview of the topic of pharmaceutical impurities including what constitutes an impurity, the various types of impurities, the regulatory guidelines and detection limits and the important points to consider during impurity testing. In addition, briefly introducing why to use reference standards and the main points to consider during their use.
Inorganic Impurity Analysis Workflows
Thursday, 13 December 2018, 11:00 CET | 10:00 GMT
During this webinar novel and existing inorganic impurities will be discussed and how ICP-MS can be utilized and optimized to obtain ultimate sensitivity and rapid detection and quantitation of such impurities. Also how automatic method development can improve productivity.
Organic Impurity Analysis Workflows
Tuesday, 15 January 2019, 11:00 CET | 10:00 GMT
Strategies will be shown to improve productivity, reduce cost per sample and gain deeper insights for organic impurity analysis using novel UHPLC and detector technology. How to achieve confirmation, identification and quantification simultaneously with a multi-detector approach. What are the benefits to using IC-MS compared to standard IC with conductivity?
Broughton Laboratories Case Studies on Pharmaceutical Impurities
Thursday, 17 January 2019, 11:00 CET | 10:00 GMT
In this webinar, Broughton Laboratories will discuss their work in the area of pharmaceutical impurities focusing on method development and validation of related substances, stability studies and impurity profiling and the investigation of unknown impurities.